ERBB2 and breast neoplasm: We contrasted immune-associated gene expression between 119 TN and 475 HR + HER2− breast tumors from The Cancer Genome Atlas (TCGA) and confirmed our findings in 299 TN and 1369 HR + HER2− breast tumors in the METABRIC database.